Email this article Design and Antitumor Activity of Platinum Complexes
- Authors: Kritchenkov A.S.1,2, Stanishevskii Y.M.2, Skorik Y.A.1,3
-
Affiliations:
- Institute of Macromolecular Compounds, Russian Academy of Sciences, Bol’shoi Prospect, Vasilevskii Island
- Russian University of the Friendship of the Peoples
- V. A. Almazov National Medical Research Center
- Issue: Vol 53, No 1 (2019)
- Pages: 6-14
- Section: Search for New Drugs
- URL: https://ogarev-online.ru/0091-150X/article/view/245590
- DOI: https://doi.org/10.1007/s11094-019-01947-8
- ID: 245590
Cite item
Open Access
Access granted
Subscription Access
Abstract
This review presents the main advances in the design of antitumor platinum complexes over the last five years. Particular attention is paid to unconventional antitumor platinum compounds (complexes in the trans configuration, Pt(IV) complexes with S and P donor ligands, multinuclear complexes).
Keywords
About the authors
A. S. Kritchenkov
Institute of Macromolecular Compounds, Russian Academy of Sciences, Bol’shoi Prospect, Vasilevskii Island; Russian University of the Friendship of the Peoples
Email: yury_skorik@mail.ru
Russian Federation, St. Petersburg, 199004; 6 Miklukho-Maklaya Street, Moscow, 17198
Ya. M. Stanishevskii
Russian University of the Friendship of the Peoples
Email: yury_skorik@mail.ru
Russian Federation, 6 Miklukho-Maklaya Street, Moscow, 17198
Yu. A. Skorik
Institute of Macromolecular Compounds, Russian Academy of Sciences, Bol’shoi Prospect, Vasilevskii Island; V. A. Almazov National Medical Research Center
Author for correspondence.
Email: yury_skorik@mail.ru
Russian Federation, St. Petersburg, 199004; 2 Akkuratov Street, St. Petersburg, 197341
Supplementary files
